Imaging Therapeutic Response to Immunosuppression in IgG4-Related Coronary Disease: the role of coronary wall enhancement CMR
Glucocorticoid combined with steroid-sparing immunosuppression therapy is effective in treating IgG4-RD with coronary involvement. Coronary wall CE on CMR emerges as a valuable imaging biomarker that complements serological markers in assessing treatment response. Incorporating coronary wall CE enhances Responder Index scoring, aiding therapeutic decisions and disease monitoring.
Authors
- Xiaohan Qu (ORCID: https://orcid.org/0000-0003-1494-2333)
- Guan Wang (ORCID: https://orcid.org/0000-0001-8626-5824)
- Yaqi Du
- Yun Bai
- Ping Xu
- Shuang Ding
- Yiqin Wang
- Jiayi Wei
- Pingting Yang
- Ranran Zhang
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Cardiovascular Magnetic Resonance
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.jocmr.2025.102680
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00